Truly Understand the News.
Published loading...Updated

First Patients Enrolled in Trial on Anti-HER2 Therapy in HER2+ Breast Cancer

Summary by curetoday.com
The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ breast cancer using circulating tumor DNA.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Reporter.lu broke the news in Luxembourg District, Luxembourg on Wednesday, March 12, 2025.
Sources are mostly out of (0)